Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-24-002949

President and CEO acquired 10,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shukla Sanjay President and CEO 2024-02-05 Option exercise +10,375 116,548 D
Derivatives
Shukla Sanjay President and CEO 2024-02-05 Option exercise · Restricted Stock Unit −10,375 20,750 D
Loading xslF345X05/doc4.xml…